Advanced search
Publication Cover
Leukemia & Lymphoma Volume 10, 1993 - Issue sup1
Submit an article Journal homepage
34
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Chronic Administration of Etoposide in the Treatment of Non-Hodgkin's Lymphoma

John D. Hainsworth Division of Oncology, Vanderbilt University, Nashville, Tennessee, USA
Pages 65-72 | Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Akihiro Ohmoto & Shigeo Fuji. (2021) Clinical feasibility of oral low-dose etoposide and sobuzoxane for conventional chemotherapy–intolerant lymphoma patients. Expert Review of Anticancer Therapy 21:7, pages 715-722.
Read now
Mary J Ninan & Vicki A Morrison. (2009) Therapeutic approaches to non-Hodgkin’s lymphoma in the elderly patient. Expert Review of Hematology 2:2, pages 173-182.
Read now
Scott H. Kaufmann, Judith E. Karp, Philip J. Burke & Steven D. Gore. (1996) Addition of Etoposide to Initial Therapy of Adult Acute Lymphoblastic Leukemia: A Combined Clinicaland Laboratory Study. Leukemia & Lymphoma 23:1-2, pages 71-83.
Read now
Paul Goss, Ronald Burkes, Leona Rudinskas, Michael King, Winston Chow, Robert Myers, Murray Davidson, Peeter Poldre, Michael Crump, David Sutton & Gerald Scott. (1995) A Phase II Trial of Prednisone, Oral Etoposide, and Novantrone (PEN) as Initial Treatment of Non-Hodgkin's Lymphoma in Elderly Patients. Leukemia & Lymphoma 18:1-2, pages 145-152.
Read now

Articles from other publishers (12)

Matthias A. Fante, Mona Felsenstein, Stephanie Mayer, Michael Gerken, Monika Klinkhammer-Schalke, Wolfgang Herr, Martin Vogelhuber, Albrecht Reichle & Daniel Heudobler. (2022) All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma. Frontiers in Oncology 12.
Crossref
Lonzetta Neal, Nicole Sookhan & Carol Reynolds. (2009) Occult Breast Carcinoma Presenting as Gastrointestinal Metastases. Case Reports in Medicine 2009, pages 1-3.
Crossref
Morton Coleman, Peter Martin, Jia Ruan, Richard Furman, Ruben Niesvizky, Rebecca Elstrom, Patricia George, Thomas P. Kaufman & John P. Leonard. (2008) Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: Low-dose metronomic, multidrug therapy. Cancer 112:10, pages 2228-2232.
Crossref
Thomas M. Habermann & Mark R. Pittelkow. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2405 2424 .
Luigi Rigacci, Andrea Carpaneto, Renato Alterini, Valentina Carrai, Franco Bernardi, Giampiero Bellesi, Giovanni Longo, Alberto Bosi & Pierluigi Rossi Ferrini. (2002) Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen. Cancer 97:1, pages 97-104.
Crossref
David N. Korones, Paul G. Fisher, Kenneth J. Cohen & Ronald L. Dubowy. (2000) No responses to oral etoposide in 15 patients with recurrent brain tumors. Medical and Pediatric Oncology 35:1, pages 80-82.
Crossref
F. Celsing, S. Widell, K. Merk, P. Bernell, G. Grimfors, A. Hedlund, J. Liliemark, E. Svedmyr, E. Ösby & M. Björkholm. (1998) Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin’s lymphoma. Annals of Oncology 9:11, pages 1213-1217.
Crossref
S. Joel, K. O’Byrne, R. Penson, D. Papamichael, A. Higgins, H. Robertshaw, R. Rudd, D. Talbot & M. Slevin. (1998) A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer. Annals of Oncology 9:11, pages 1205-1211.
Crossref
Umberto Tirelli, Vittorina Zagonel, Domenico Errante, Lucia Fratino & Silvio Monfardini. (1998) Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematological Oncology 16:1, pages 1-13.
Crossref
A. Davidson, R. Gowing, S. Lowis, D. Newell, I. Lewis, C. Dicks-Mireaux & C.R. Pinkerton. (1997) Phase II study of 21 day schedule oral etoposide in children. European Journal of Cancer 33:11, pages 1816-1822.
Crossref
D.A Cameron, J.M White, S.J Proctor, R.J Prescott, R.C.F Leonard, B Angus, M.K Cook, P.J.D.K Dawes, A.A Dawson, R.G.B Evans, M.J Galloway, A.L Harris, A Heppleston, C.H.W Home, A.S Krajewski, A.L Lennard, A.M Lessells, H.H Lucraft, J.B MacGillivray, M.J Mackie, A.C Parker, J.T Roberts, P.R.A Taylor & W.D Thompson. (1997) CHOP-based Chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. European Journal of Cancer 33:8, pages 1195-1201.
Crossref
Simon Joel. (1996) The clinical pharmacology of etoposide: an update. Cancer Treatment Reviews 22:3, pages 179-221.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.